Company Filing History:
Years Active: 2023-2025
Title: Jackson Eby: Innovator in Cancer Treatment
Introduction
Jackson Eby is a notable inventor based in Arlington, MA (US), recognized for his contributions to the field of cancer treatment. With a total of 2 patents to his name, Eby has made significant strides in developing immunogenic compositions that target diseases associated with anaplastic lymphoma kinase (ALK).
Latest Patents
Eby's latest patents include innovative methods involving ALK polypeptides. The first patent features immunogenic compositions containing ALK polypeptides and outlines methods of use for treating diseases associated with ALK in subjects, particularly focusing on various forms of cancer, including solid tumor cancers and ALK+ cancers. This invention holds promise for advancing therapeutic options in oncology.
Career Highlights
Eby is currently affiliated with Elicio Therapeutics, Inc., where he continues to work on groundbreaking research and development in the field of immunotherapy. His expertise in ALK-related treatments positions him as a key player in the fight against cancer.
Collaborations
Some of Eby's notable coworkers include Adrienne Li and Peter C Demuth, who contribute to the collaborative efforts at Elicio Therapeutics, Inc. Their combined expertise enhances the innovative environment necessary for developing effective cancer treatments.
Conclusion
Jackson Eby is a prominent inventor whose work in immunogenic compositions and ALK polypeptides is paving the way for new cancer therapies. His contributions are vital to advancing medical science and improving patient outcomes.